It’s been a long time coming, but Canada’s Liberal government is expected to announce plans next month to legalize cannabis in the country. According to CBC News, the announcement will be made the week of April 10, and the goal will be to legalize marijuana by July 1, 2018.
Other publications have suggested that the news will be released on different dates. The Globe and Mail says it will come on April 20, or 4/20, while in a statement to Global News, Justice Minister Jody-Wilson-Raybould said that legalization will be introduced this spring, but didn’t provide a specific date.
“Our government is committed to introducing legislation this spring that would, as promised, legalize, strictly regulate, and restrict access to cannabis,” Wilson-Raybould said. “In order to meet our commitment to legalize, the legislation will need to pass through the parliamentary process in a timely fashion.”


While it may be over a year until marijuana is officially legalized, a report released last year by Canada’s Task Force on Cannabis Legalization and Regulation has already made 80 recommendations for framing legalization effectively.
Among other things, the report recommends that the federal government use licensing and production controls and enforce a minimum purchasing age of 18. Provincial governments will manage distribution and pricing, and will have the authority to set a higher minimum purchasing age.
Households will be able to grow up to four plants, says CBC News.
The news outlet’s report came the same day as the NDP met in Montreal for a leadership debate. At the event, party members criticized the Liberal government’s “promise to legalize pot,” says Global News.
“I believe in legalization,” BC MP Peter Julian was quoted as saying. “I do not believe Justin Trudeau is going to bring in the legalization of marijuana and as proof that … we are still seeing, particularly young Canadians, being criminalized by simple possession of marijuana.”

US Election 2020 and Cannabis

 
Investing in cannabis? Read what experts have to say about cannabis and the US Election!
 


Canadian cannabis stocks have performed well following the news that legalization is impending. Gainers include:
  • Canopy Growth (TSX:WEED) — up 9.11 percent at $10.79
  • Aurora Cannabis (TSXV:ACB) — up 8.33 percent at $2.48
  • Tetra Bio-Pharma (CNSX:TBP) — up 9.37 percent at $0.70
  • Emblem (TSXV:EMC) — up 4.7 percent at $2.45
  • Maple Leaf Green World (TSXV:MGW) — up 7.69 percent at $0.55

Don’t forget to follow us @INN_Resource for real-time news updates!
Securities Disclosure: I, Jocelyn Aspa, hold no direct investment interest in any company mentioned in this article.
Editorial Disclosure: Maple Leaf Green World is a client of the Investing News Network. This article is not paid-for content.

Pawar Law Group announces that a class action lawsuit has been filed on behalf of shareholders who purchased shares of Aurora Cannabis Inc. (NYSE: ACB) from February 13, 2020 through September 4, 2020, inclusive (the “Class Period”). The lawsuit seeks to recover damages for Aurora Cannabis Inc. investors under the federal securities laws.

To join the class action, go here or call Vik Pawar, Esq. toll-free at 888-589-9804 or email info@pawarlawgroup.com for information on the class action.

Keep reading... Show less

The Israeli cannabis market is picking up with a new supply deal from a Canadian producer.

Also this week, new data showed sales of Canadian cannabis edible products may be stalling.

Keep reading... Show less

The Israeli cannabis market is picking up as a Canadian producer announced a new supply deal in the country.

Also this week it was shown the sales of Canadian cannabis edible products may be stalling, according to new data.

Keep reading... Show less

The Portnoy Law Firm advises investors that class action lawsuits have been filed on behalf of investors in the following publicly traded companies. Shareholders interested in taking an active role in these cases have until the deadlines indicated below to petition the court. There is no cost or obligation to you. See below for more information on these cases.

Credit Acceptance Corporation investors (NASDAQ: CACC); December 1, 2020 deadline, click here to join .

Keep reading... Show less
  • On November 19 , the Mexican Senate passed comprehensive adult-use cannabis legalization, moving Mexico towards becoming one of the few countries to legalize cannabis nationally
  • On March 31, 2020 , the Company entered into an agreement with Tecnologico de Monterrey , the leading university in Mexico , to educate physicians across Latin America , in advance of the impending regulations in Mexico
  • To date, close to 550 LatAm physicians have obtained their diploma accrediting completion of Khiron’s medical education program
  • The Company plans to deploy its ZereniaTM medical cannabis clinics and telehealth strategy in Mexico , building on the success of its vertical integration strategy in Colombia
  • Expanding the Zerenia clinic strategy will build on the Company’s Colombia knowledge and proven distribution capabilities, with rapid telehealth service adoption and over 5,600 medical cannabis scripts filled to date
  • Mexico represents one of the largest potential markets for medical cannabis in the world and is anticipated to reach $1.2bn USD by 2028 (Prohibition Partners).
  • Company to release Q3 2020 financials and host webcast on Tuesday, December 1st

Khiron Life Sciences Corp. (“Khiron” or the “Company”) (TSXV: KHRN ), (OTCQX: KHRNF), ( Frankfurt : A2JMZC), a vertically integrated cannabis leader with core operations in Latin America and Europe welcomes the passing of adult-use cannabis legislation by the Mexican Senate, which moves the country closer to a legalized cannabis market, and towards provision for medical cannabis products.  Khiron has had a presence in Mexico since 2018 and has been working with doctors and medical institutions to develop a deep understanding of the market.

Keep reading... Show less